Introduced by Dr. Børge Diderichsen (member of OECD Working Party on Biotechnology and European Research Council), Life Sciences Partners (Holland) investment and cooperation forum was held in Chinese National Compound Library (CNCL) on December 6, 2011. Amongst over 20 attendants are representatives from more than a dozen local institutions. Professor WANG Mingwei, Director of the National Center for Drug Screening hosted the event.
Mr. Martijn Kleijwegt, managing partner and co-founder of LSP and Dr. Joep Muijrers, Partner of LSP briefly introduced LSP and the purpose of their trip. Ranked the number 1 among life science investors in Europe, LSP has significant experience and excellent track record in healthcare and biotech investing. To capture opportunities created by the rapid development in Chinese scientific innovation, biopharmaceutical investment and technology transfer, LSP intends to establish a dedicated China Fund to invest in entrepreneuric and innovation activities, by use of its rich professional expertise and vast social network.
The participants individually presented their own experience and plan in drug development, technology transfer and capital investment, followed by serious discussions on the aspects of mutual interest. During the interval, they toured the brand new facility of CNCL and were highly inspired by its grand scale and state-of-the-art setup.